ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. (2022)
Attributed to:
Trials Methodology Research Partnership
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/13993003.02006-2021
PubMed Identifier: 34649975
Publication URI: http://europepmc.org/abstract/MED/34649975
Type: Journal Article/Review
Volume: 59
Parent Publication: The European respiratory journal
Issue: 5
ISSN: 0903-1936